Boston Scientific (BSX) Stock Falls After Cyberattack Wipes Out Earnings Guidance

TLDR

• Boston Scientific stock dropped 2.3% in premarket trading after warning it will likely miss its Q3 and full-year 2026 guidance.
• The guidance warning is directly tied to the cyberattack discovered on August 25.
• The company previously forecast full-year sales growth of 5.5% to 6.5% and adjusted EPS of $3.28 to $3.32.
• BSX stock is down 50% year-to-date and 55% over the past 12 months, sitting far below its 52-week high of $109.50.
• TD Cowen kept its Buy rating and $56 price target, but the positive note was overshadowed by the formal financial warning.

Boston Scientific (BSX) stock dropped 2.3% to $46.68 in premarket trading on Tuesday after the company formally warned it will likely miss its earnings and sales guidance for Q3 and full-year 2026.

Boston Scientific Corporation, BSX

The warning is a direct result of the cyberattack the company disclosed on August 25. In a regulatory filing Tuesday, BSX said it is “unlikely to meet” its net sales growth and adjusted EPS guidance ranges for both the third quarter and the full year.

… Continue reading the full article at the original source below.